| 000 | 01671 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250512140014.0 | ||
| 264 | 0 | _c19710706 | |
| 008 | 197107s 0 0 eng d | ||
| 022 | _a0025-7125 | ||
| 024 | 7 |
_a10.1016/s0025-7125(16)32512-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLee, B J | |
| 245 | 0 | 0 |
_aThe management of plasma cell neoplasms. _h[electronic resource] |
| 260 |
_bThe Medical clinics of North America _cMay 1971 |
||
| 300 |
_a703-19 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Review | ||
| 650 | 0 | 4 |
_aAmyloid _xbiosynthesis |
| 650 | 0 | 4 |
_aAmyloidosis _xcomplications |
| 650 | 0 | 4 |
_aAnemia _xetiology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
| 650 | 0 | 4 |
_aHodgkin Disease _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunodiffusion |
| 650 | 0 | 4 | _aImmunoelectrophoresis |
| 650 | 0 | 4 |
_aImmunoglobulin G _xanalysis |
| 650 | 0 | 4 |
_aImmunoglobulin M _xanalysis |
| 650 | 0 | 4 |
_aImmunoglobulins _xanalysis |
| 650 | 0 | 4 |
_aInfections _xetiology |
| 650 | 0 | 4 |
_aLeukemia, Lymphoid _xcomplications |
| 650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xcomplications |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xcomplications |
| 650 | 0 | 4 |
_aMelphalan _xtherapeutic use |
| 650 | 0 | 4 |
_aMultiple Myeloma _xcomplications |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aPyelonephritis _xetiology |
| 700 | 1 | _aPinsky, C | |
| 700 | 1 | _aMiller, D G | |
| 773 | 0 |
_tThe Medical clinics of North America _gvol. 55 _gno. 3 _gp. 703-19 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0025-7125(16)32512-3 _zAvailable from publisher's website |
| 999 |
_c4998457 _d4998457 |
||